FDA approves first emergency treatment for chemotherapy overdose savita14 Dec 2015 11:49 AM ISTThe U.S. Food and Drug Administration approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an...
Nadda lays National Cancer Institute's foundation stone in Jhajjar Meghna A Singhania13 Dec 2015 3:04 PM ISTJhajjar (Haryana): Union Health Minister J P Nadda, who on Saturday laid the foundation stone of the National Cancer Institute (NCI) here, said the...
Roche gets accelerated U.S. approval for lung cancer drug Meghna A Singhania13 Dec 2015 2:55 PM ISTU.S. health regulators on Friday said they have granted accelerated approval to Roche Holding's drug for advanced lung cancer in patients with a...
FDA approves Genentech drug for advanced lung cancer savita13 Dec 2015 2:39 PM ISTThe Food and Drug Administration has approved an experimental Genetech drug for patients with a certain type of lung cancer who have few other...
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ savita12 Dec 2015 11:14 AM ISTBritish drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion (3.3...
Cancer cases among women on the rise: Govt savita12 Dec 2015 11:12 AM ISTNew Delhi: There has been a spike in cancer cases among women over recent years with breast cancer being of particular concern as it is found to be...
Every 13th new cancer patient is an Indian: Nadda savita7 Dec 2015 1:23 PM ISTNew Delhi: Every 13th new cancer patient in the world is an Indian as the country shares 7.5 per cent of global cancer burden, Health Minister JP...
New drug found more effective for chronic leukemia patients savita7 Dec 2015 1:18 PM ISTNew York: Older adults with chronic lymphocytic leukemia, a type of slow-growing blood cancer, may have a better alternative to toxic chemotherapy as...
FDA approves Portrazza to treat advanced squamous non-small cell lung cancer savita3 Dec 2015 3:02 PM ISTThe U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced...
FDA approves Empliciti to treat multiple myeloma Meghna A Singhania3 Dec 2015 12:35 PM ISTToday the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with...
IBM Watson to power Manipal Hospitals' cancer care savita3 Dec 2015 11:37 AM ISTIn a first, hospital chain Manipal Hospitals has adopted IBM watson cognitive computing platform for improving and offering individualised cancer care...
Over 800,000 lung cancer patients in China by 2020 savita2 Dec 2015 10:59 AM ISTBeijing: China is expected to have over 800,000 lung cancer patients diagnosed annually by 2020, with nearly 700,000 people dying from the disease...
